Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity.
Saved in:
| Title: | Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. |
|---|---|
| Authors: | Shen S; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Sckisel G; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Sahoo A; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Lalani A; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Otter DD; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Pearson J; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States., DeVoss J; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Cheng J; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Casey SC; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States., Case R; Discovery Attribute Sciences, Amgen Research, South San Francisco, CA, United States., Yang M; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States., Low R; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States., Daris M; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States., Fan B; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States., Agrawal NJ; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States., Ali K; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2020 May 08; Vol. 11, pp. 832. Date of Electronic Publication: 2020 May 08 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32457754 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shen+S%22">Shen S</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Sckisel+G%22">Sckisel G</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Sahoo+A%22">Sahoo A</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lalani+A%22">Lalani A</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Otter+DD%22">Otter DD</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Pearson+J%22">Pearson J</searchLink>; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22DeVoss+J%22">DeVoss J</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cheng+J%22">Cheng J</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Casey+SC%22">Casey SC</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Case+R%22">Case R</searchLink>; Discovery Attribute Sciences, Amgen Research, South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Low+R%22">Low R</searchLink>; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Daris+M%22">Daris M</searchLink>; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Fan+B%22">Fan B</searchLink>; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Agrawal+NJ%22">Agrawal NJ</searchLink>; Biologics Discovery, Amgen Research, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ali+K%22">Ali K</searchLink>; Departments of Oncology Research, Amgen Research, South San Francisco, CA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 May 08; Vol. 11, pp. 832. <i>Date of Electronic Publication: </i>2020 May 08 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32457754 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2020.00832 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 832 Titles: – TitleFull: Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shen S – PersonEntity: Name: NameFull: Sckisel G – PersonEntity: Name: NameFull: Sahoo A – PersonEntity: Name: NameFull: Lalani A – PersonEntity: Name: NameFull: Otter DD – PersonEntity: Name: NameFull: Pearson J – PersonEntity: Name: NameFull: DeVoss J – PersonEntity: Name: NameFull: Cheng J – PersonEntity: Name: NameFull: Casey SC – PersonEntity: Name: NameFull: Case R – PersonEntity: Name: NameFull: Yang M – PersonEntity: Name: NameFull: Low R – PersonEntity: Name: NameFull: Daris M – PersonEntity: Name: NameFull: Fan B – PersonEntity: Name: NameFull: Agrawal NJ – PersonEntity: Name: NameFull: Ali K IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2020 May 08 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |